Global Stem Cells Market to Reach $19.1 Billion by 2030
NEW YORK, March 14, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Read the full report: https://www.reportlinker.com/p02043289/?utm_source=PRN
Global Stem Cells Market to Reach $19.1 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Stem Cells estimated at US$10.7 Billion in the year 2022, is projected to reach a revised size of US$19.1 Billion by 2030, growing at aCAGR of 7.4% over the period 2022-2030. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$16 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 6.8% CAGR
The Stem Cells market in the U.S. is estimated at US$3.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.
Select Competitors (Total 233 Featured)
- apceth Biopharma GmbH
- Athersys Inc.
- AVIVA BioSciences Corporation
- BioE Inc.
- Bone Therapeutics SA
- Cesca Therapeutics Inc.
- Cryo-Cell International Inc.
- Cytori Therapeutics Inc.
- ESI BIO
- Gamida Cell Ltd.
- Holostem Terapie Avanzate
- International Stem Cell Corp.
- Kangstem Biotech. Ltd.
- Lonza Group Ltd.
- Mesoblast Ltd.
- Neuralstem Inc.
- Nuvasive Inc.
- OncoMed Pharmaceuticals Inc.
- Osiris Therapeutics Inc.
- Promethera Biosciences S.A.N.V
- Reliance Life Sciences
- ReNeuron Group Plc.
- Stemcell Technologies Inc.
- Stemedica Cell Technologies Inc.
- Stempeutics Research Pvt. Ltd.
- Takara Bio USA Inc.
- TiGenix NV
- U.S Stem Cell Inc.
- ViaCord
Read the full report: https://www.reportlinker.com/p02043289/?utm_source=PRN
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Stem Cells - Offering Potential for Breakthrough Therapeutic
Discoveries
Recent Market Activity
Select Approved Stem Cell Products
Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
Trends Related to Stem Cell Clinical Trials
Select Stem Cell Pipeline Analysis
Current & Future Analysis
Stem Cell Research Funding Policies across the World
Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC)
Research
Adult Stem Cells Deemed More Ethical, More Research Needed to
Increase Clinical Applications
Dental Mesenchymal Stem Cells - Emergence of a Niche Market
For-Profit, Unregulated Clinics: The Flipside of Stem Cell
Research
Unproven Therapies Do Online Rounds as Effective Treatment
Options - A Cause of Concern
Stem Cells - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
Athersys, Inc. (USA)
Apceth GmbH & Co.KG (Germany)
AVIVA BioSciences Corporation (USA)
BioE, Inc. (USA)
Bone Therapeutics SA (Belgium)
Cesca Therapeutics, Inc. (USA)
Cryo-Cell International, Inc. (USA)
Cytori Therapeutics, Inc. (USA)
ESI BIO, a Division of BioTime Inc. (USA)
Gamida Cell Ltd. (Israel)
Holostem Terapie Avanzate (Italy)
International Stem Cell Corporation (USA)
Kangstem Biotech., Ltd. (Korea)
Lonza Group Ltd (Switzerland)
Mesoblast Ltd. (Australia)
Neuralstem, Inc. (USA)
Nuvasive, Inc. (USA)
Osiris Therapeutics, Inc. (USA)
OncoMed Pharmaceuticals, Inc (USA)
PROMETHERA Biosciences S.A.N.V (Belgium)
Reliance Life Sciences (India)
ReNeuron Group Plc. (UK)
STEMCELL Technologies, Inc. (Canada)
Stemedica Cell Technologies, Inc (USA)
Stempeutics Research Pvt. Ltd. (India)
Takara Bio USA Inc (USA)
TiGenix NV (Belgium)
U.S Stem Cell, Inc. (USA)
ViaCord, LLC (USA)
3. MARKET TRENDS & DRIVERS
Researchers at UCLA Successfully Develop 3D Lung Organoids
using Stem Cells
Embryonic Stem Cell Gene Nanog Found to Reverse Aging
Canadian and Dutch Scientists Finds the ?Genetic Switch? to
Increase Stem Cell Volume from Cord Blood
The Boston Program Pioneers Cell-based Personalized Diabetes
Treatment
iPSCs Provide Valuable Source for Retinal Transplants and Other
Applications
Albumin-Free Culture of Pluripotent Stem Cells Enables
Application in Cardiac Disorders
Stem Cell Therapy - An Alternative to Orthopedic Surgery in
Younger Patients?
Application of Plant Stem Cells in Cosmetic Treatments - Myths
Busted
Adverse Reactions of Stem Cell-Face Lift Therapy
Stem Cell-Breast Enhancement
Other Innovations Using Stem Cells
New Stem Cell Software & Products
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Stem
Cells by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR
Table 2: World 8-Year Perspective for Stem Cells by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets
for Years 2023 & 2030
Table 3: World Recent Past, Current & Future Analysis for Adult
Stem Cells by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 4: World 8-Year Perspective for Adult Stem Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030
Table 5: World Recent Past, Current & Future Analysis for Other
Product Types by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 6: World 8-Year Perspective for Other Product Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Regenerative Medicine by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 8: World 8-Year Perspective for Regenerative Medicine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030
Table 9: World Recent Past, Current & Future Analysis for Drug
Discovery & Development by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 10: World 8-Year Perspective for Drug Discovery &
Development by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2023 & 2030
Table 11: World Stem Cells Market Analysis of Annual Sales in
US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2023 (E)
Table 12: USA Recent Past, Current & Future Analysis for Stem
Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 13: USA 8-Year Perspective for Stem Cells by Product Type -
Percentage Breakdown of Value Sales for Adult Stem Cells and
Other Product Types for the Years 2023 & 2030
Table 14: USA Recent Past, Current & Future Analysis for Stem
Cells by Application - Regenerative Medicine and Drug Discovery &
Development - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 15: USA 8-Year Perspective for Stem Cells by Application -
Percentage Breakdown of Value Sales for Regenerative Medicine
and Drug Discovery & Development for the Years 2023 & 2030
CANADA
Table 16: Canada Recent Past, Current & Future Analysis for
Stem Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 17: Canada 8-Year Perspective for Stem Cells by Product
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and Other Product Types for the Years 2023 & 2030
Table 18: Canada Recent Past, Current & Future Analysis for
Stem Cells by Application - Regenerative Medicine and Drug
Discovery & Development - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 19: Canada 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
JAPAN
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2023 (E)
Table 20: Japan Recent Past, Current & Future Analysis for Stem
Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 21: Japan 8-Year Perspective for Stem Cells by Product
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and Other Product Types for the Years 2023 & 2030
Table 22: Japan Recent Past, Current & Future Analysis for Stem
Cells by Application - Regenerative Medicine and Drug Discovery &
Development - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 23: Japan 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
CHINA
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2023 (E)
Table 24: China Recent Past, Current & Future Analysis for Stem
Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 25: China 8-Year Perspective for Stem Cells by Product
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and Other Product Types for the Years 2023 & 2030
Table 26: China Recent Past, Current & Future Analysis for Stem
Cells by Application - Regenerative Medicine and Drug Discovery &
Development - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 27: China 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
EUROPE
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2023 (E)
Table 28: Europe Recent Past, Current & Future Analysis for
Stem Cells by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 29: Europe 8-Year Perspective for Stem Cells by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2023 & 2030
Table 30: Europe Recent Past, Current & Future Analysis for
Stem Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 31: Europe 8-Year Perspective for Stem Cells by Product
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and Other Product Types for the Years 2023 & 2030
Table 32: Europe Recent Past, Current & Future Analysis for
Stem Cells by Application - Regenerative Medicine and Drug
Discovery & Development - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 33: Europe 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
FRANCE
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2023 (E)
Table 34: France Recent Past, Current & Future Analysis for
Stem Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 35: France 8-Year Perspective for Stem Cells by Product
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and Other Product Types for the Years 2023 & 2030
Table 36: France Recent Past, Current & Future Analysis for
Stem Cells by Application - Regenerative Medicine and Drug
Discovery & Development - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 37: France 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
GERMANY
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2023 (E)
Table 38: Germany Recent Past, Current & Future Analysis for
Stem Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 39: Germany 8-Year Perspective for Stem Cells by Product
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and Other Product Types for the Years 2023 & 2030
Table 40: Germany Recent Past, Current & Future Analysis for
Stem Cells by Application - Regenerative Medicine and Drug
Discovery & Development - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 41: Germany 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
ITALY
Table 42: Italy Recent Past, Current & Future Analysis for Stem
Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 43: Italy 8-Year Perspective for Stem Cells by Product
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and Other Product Types for the Years 2023 & 2030
Table 44: Italy Recent Past, Current & Future Analysis for Stem
Cells by Application - Regenerative Medicine and Drug Discovery &
Development - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 45: Italy 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
UNITED KINGDOM
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2023 (E)
Table 46: UK Recent Past, Current & Future Analysis for Stem
Cells by Product Type - Adult Stem Cells and Other Product
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2022 through 2030 and % CAGR
Table 47: UK 8-Year Perspective for Stem Cells by Product Type -
Percentage Breakdown of Value Sales for Adult Stem Cells and
Other Product Types for the Years 2023 & 2030
Table 48: UK Recent Past, Current & Future Analysis for Stem
Cells by Application - Regenerative Medicine and Drug Discovery &
Development - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 49: UK 8-Year Perspective for Stem Cells by Application -
Percentage Breakdown of Value Sales for Regenerative Medicine
and Drug Discovery & Development for the Years 2023 & 2030
REST OF EUROPE
Table 50: Rest of Europe Recent Past, Current & Future Analysis
for Stem Cells by Product Type - Adult Stem Cells and Other
Product Types - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 51: Rest of Europe 8-Year Perspective for Stem Cells by
Product Type - Percentage Breakdown of Value Sales for Adult
Stem Cells and Other Product Types for the Years 2023 & 2030
Table 52: Rest of Europe Recent Past, Current & Future Analysis
for Stem Cells by Application - Regenerative Medicine and Drug
Discovery & Development - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 53: Rest of Europe 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
ASIA-PACIFIC
Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Asia-Pacific for 2023 (E)
Table 54: Asia-Pacific Recent Past, Current & Future Analysis
for Stem Cells by Product Type - Adult Stem Cells and Other
Product Types - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 55: Asia-Pacific 8-Year Perspective for Stem Cells by
Product Type - Percentage Breakdown of Value Sales for Adult
Stem Cells and Other Product Types for the Years 2023 & 2030
Table 56: Asia-Pacific Recent Past, Current & Future Analysis
for Stem Cells by Application - Regenerative Medicine and Drug
Discovery & Development - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 57: Asia-Pacific 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
REST OF WORLD
Table 58: Rest of World Recent Past, Current & Future Analysis
for Stem Cells by Product Type - Adult Stem Cells and Other
Product Types - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 59: Rest of World 8-Year Perspective for Stem Cells by
Product Type - Percentage Breakdown of Value Sales for Adult
Stem Cells and Other Product Types for the Years 2023 & 2030
Table 60: Rest of World Recent Past, Current & Future Analysis
for Stem Cells by Application - Regenerative Medicine and Drug
Discovery & Development - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 61: Rest of World 8-Year Perspective for Stem Cells by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine and Drug Discovery & Development for the
Years 2023 & 2030
IV. COMPETITION
Read the full report: https://www.reportlinker.com/p02043289/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article